Biotoxtech Co. Ltd (086040) - Total Liabilities

Latest as of September 2025: ₩98.39 Billion KRW ≈ $66.68 Million USD

Based on the latest financial reports, Biotoxtech Co. Ltd (086040) has total liabilities worth ₩98.39 Billion KRW (≈ $66.68 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Biotoxtech Co. Ltd (086040) cash conversion ratio to assess how effectively this company generates cash.

Biotoxtech Co. Ltd - Total Liabilities Trend (2011–2024)

This chart illustrates how Biotoxtech Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. Check Biotoxtech Co. Ltd (086040) asset resilience to evaluate the company's liquid asset resilience ratio.

Biotoxtech Co. Ltd Competitors by Total Liabilities

The table below lists competitors of Biotoxtech Co. Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
NXT Energy Solutions Inc TO:SFD	Canada	CA$5.56 Million
NextCure Inc NASDAQ:NXTC	USA	$15.97 Million
Aligos Therapeutics Inc NASDAQ:ALGS	USA	$36.04 Million
Seoyon Topmetal Co. Ltd KQ:019770	Korea	₩68.01 Billion
OnKure Therapeutics, Inc. NASDAQ:OKUR	USA	$6.41 Million
Ma Kuang Healthcare Holding Ltd TWO:4139	Taiwan	NT$844.71 Million
Radiant Globaltech Bhd KLSE:0202	Malaysia	RM65.60 Million
Wemade Max Co. Ltd KQ:101730	Korea	₩108.81 Billion

Liability Composition Analysis (2011–2024)

This chart breaks down Biotoxtech Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Biotoxtech Co. Ltd (086040) total market value.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.63	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	2.33	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.74	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Biotoxtech Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Biotoxtech Co. Ltd (2011–2024)

The table below shows the annual total liabilities of Biotoxtech Co. Ltd from 2011 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩96.11 Billion ≈ $65.13 Million	-2.73%
2023-12-31	₩98.80 Billion ≈ $66.96 Million	+21.28%
2022-12-31	₩81.47 Billion ≈ $55.21 Million	+64.25%
2021-12-31	₩49.60 Billion ≈ $33.61 Million	+64.61%
2020-12-31	₩30.13 Billion ≈ $20.42 Million	+0.49%
2019-12-31	₩29.98 Billion ≈ $20.32 Million	-5.95%
2018-12-31	₩31.88 Billion ≈ $21.61 Million	-3.91%
2017-12-31	₩33.18 Billion ≈ $22.49 Million	+41.39%
2016-12-31	₩23.47 Billion ≈ $15.90 Million	+7.67%
2015-12-31	₩21.79 Billion ≈ $14.77 Million	+3.04%
2014-12-31	₩21.15 Billion ≈ $14.33 Million	+2.21%
2013-12-31	₩20.69 Billion ≈ $14.02 Million	+10.34%
2012-12-31	₩18.75 Billion ≈ $12.71 Million	-16.47%
2011-12-31	₩22.45 Billion ≈ $15.22 Million	--

About Biotoxtech Co. Ltd

KQ:086040 Korea Biotechnology & Medical Research

Market Cap

$32.80 Million

₩48.40 Billion KRW

Market Cap Rank

#23418 Global

#1665 in Korea

Share Price

₩3325.00

Change (1 day)

-1.34%

52-Week Range

₩2525.00 - ₩3925.00

All Time High

₩23000.00